Sino Biopharmaceutical Limited Share Price
Equities
1177
KYG8167W1380
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.270 HKD | +1.93% |
|
-5.72% | -14.72% |
| 11/05 | Global markets live: Alphabet, Cerebras, Compass, GSK, Rockwool… |  |
| 11/05 | Hong Kong Stocks Little Changed as U.S.-Iran Talks Remain Deadlocked; LDROBOT Gains on Debut | MT |
| Capitalization | 8.01TCr 9.23TCr 1.18TCr 1.01TCr 927.09Cr 875.93Cr 1.62TCr 1,13800Cr 1.64TCr 11TCr 4.3TCr 54TCr 4.42TCr 4.33TCr 1,87000Cr | P/E ratio 2026 * |
18.4x | P/E ratio 2027 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise value | 7.25TCr 8.35TCr 1.07TCr 916.87Cr 839.33Cr 793.02Cr 1.47TCr 1,03000Cr 1.49TCr 9.95TCr 3.89TCr 49TCr 4TCr 3.92TCr 1,69300Cr | EV / Sales 2026 * |
2.01x | EV / Sales 2027 * | 1.68x |
| Free-Float |
49.22% | Yield 2026 * |
1.92% | Yield 2027 * | 2.09% |
| 1 day | +1.93% | ||
| 1 week | -5.72% | ||
| Current month | -2.77% | ||
| 1 month | -9.45% | ||
| 3 months | -22.95% | ||
| 6 months | -22.50% | ||
| Current year | -14.72% |
| 1 week | 5.13 |  | 5.57 |
| 1 month | 5.13 | | 5.84 |
| Current year | 5.13 | | 7.29 |
| 1 year | 4.03 | | 9.12 |
| 3 years | 2.29 | | 9.12 |
| 5 years | 2.29 | | 9.69 |
| 10 years | 2.05 | | 11.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
S Y Tse
CEO | Chief Executive Officer | 30 | 28/07/2022 |
Chun Ling Li
DFI | Director of Finance/CFO | 55 | 01/01/1996 |
Hsin Tse
IRC | Investor Relations Contact | 56 | 25/04/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Tse
CHM | Chairman | 74 | 02/02/2000 |
Hsin Tse
BRD | Director/Board Member | 56 | 01/08/1995 |
| Director/Board Member | 62 | 10/04/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.93% | -5.72% | +25.78% | +31.75% | 1.18TCr | |
| -0.25% | +0.31% | +36.39% | +130.32% | 91TCr | |
| -0.30% | -0.48% | +49.24% | +44.31% | 55TCr | |
| -0.68% | +1.82% | +14.85% | +46.30% | 38TCr | |
| -0.42% | +2.53% | +24.56% | +13.82% | 33TCr | |
| +0.50% | +1.34% | +33.90% | +16.15% | 29TCr | |
| -0.42% | +1.49% | +27.07% | +30.97% | 29TCr | |
| -1.09% | -0.40% | +44.93% | -2.16% | 28TCr | |
| +0.31% | -3.61% | -36.78% | -49.84% | 20TCr | |
| +0.25% | -1.45% | +20.57% | +48.41% | 18TCr | |
| Average | -0.06% | -0.18% | +24.05% | +31.00% | 34.15TCr | |
| Weighted average by Cap. | -0.39% | +1.00% | +29.53% | +51.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.61TCr 4.16TCr 530.71Cr 456.35Cr 417.76Cr 394.71Cr 729.36Cr 51TCr 741.08Cr 4.95TCr 1.94TCr 24TCr 1.99TCr 1.95TCr 84TCr | 3.92TCr 4.51TCr 576.37Cr 495.62Cr 453.71Cr 428.67Cr 792.13Cr 56TCr 804.85Cr 5.38TCr 2.1TCr 26TCr 2.16TCr 2.12TCr 92TCr |
| Net income | 426.94Cr 491.7Cr 63Cr 54Cr 49Cr 47Cr 86Cr 6.06TCr 88Cr 585.79Cr 229.22Cr 2.86TCr 235.56Cr 230.58Cr 9.97TCr | 461.22Cr 531.17Cr 68Cr 58Cr 53Cr 50Cr 93Cr 6.55TCr 95Cr 632.82Cr 247.62Cr 3.09TCr 254.47Cr 249.09Cr 11TCr |
| Net Debt | -758.25Cr -873.26Cr -111.48Cr -96Cr -88Cr -83Cr -153.21Cr -11TCr -155.67Cr -1.04TCr -407.1Cr -5.08TCr -418.35Cr -409.51Cr -18TCr | -1.43TCr -1.65TCr -210.14Cr -180.7Cr -165.42Cr -156.29Cr -288.81Cr -20TCr -293.45Cr -1.96TCr -767.38Cr -9.58TCr -788.59Cr -771.92Cr -33TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | 5.270 $ | +1.93% | 2,74,34,127 |
| 20/26/20 | 5.170 $ | -1.34% | 7,99,27,870 |
| 19/26/19 | 5.240 $ | -1.13% | 7,93,83,730 |
| 18/26/18 | 5.300 $ | -1.67% | 5,55,23,350 |
| 15/26/15 | 5.390 $ | -3.58% | 8,81,08,320 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1177 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition